REG - SSgA SPDR ETFs EurII - Prospectus / Supplements Update

State StreetAnnouncement

19/10/2022 08:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221019:nRSS3075Da&default-theme=true

RNS Number : 3075D  SSgA SPDR ETFs Europe II PLC  19 October 2022

RNS ANNOUCEMENT

Date: 19 October 2022

 

SSGA SPDR ETFs Europe II plc (the "Company")

 

CHANGES TO THE PROSPECTUS / SUPPLEMENTS

Notice of the changes effective on 28th October 2022 or such later date as the
Central Bank notes the revised Prospectus and Supplements.

 

1.   Asset Stewardship

The Asset Stewardship section of the Prospectus has been expanded to provide
further details on SSGA's engagement activities in the context of Asset
Stewardship.

2.   ESG Investing

 

Both the Principal Adverse Impacts and Taxonomy Regulation descriptions
included in the ESG Investing section of the Prospectus have been updated.

3.   Change of Index Tracking Strategy

The Index tracking strategy of the following Funds has been changed from an
optimisation strategy to a replication strategy:

 

·      SPDR STOXX Europe 600 SRI UCITS ETF

 

4.   Addition of investment limit derogation language

Investment limit derogation language has been added to the Supplements of the
equity Funds listed below which use a replication strategy. The purpose of the
update is to relax their holding limit and  allow the relevant Funds to hold
positions in individual constituents of up to 20% and to allow the relevant
Funds to continue to track their Index accurately, should the largest
constituents drift above 10% due to market movements.

 

·      SPDR EURO STOXX Low Volatility UCITS ETF

·      SPDR MSCI Europe UCITS ETF

·      SPDR MSCI World Financials UCITS ETF

·      SPDR MSCI World Health Care UCITS ETF

·      SPDR MSCI World Materials UCITS ETF

·      SPDR MSCI World Value UCITS ETF

·      SPDR STOXX Europe 600 SRI UCITS ETF

 

5.   Directory/Management

 

Updates have been made to the Directory and Management sections of the
Prospectus to reflect the resignation of Ms. Ulla Pitha and the appointment of
Ms. Marie-Anne Heeren as a director of the Management Company.

 

Availability of Prospectus & Supplements

The revised Prospectus and Supplements, which also include certain other
proposed updates, will be available from 28th October 2022 or such later date
as the Central Bank notes the revised Prospectus and Supplements, on
www.ssga.com.

Should you have any queries, please contact the SPDR ETF Sales and Support
team at spdrseurope@ssga.com / +44 (0)20 3395 6888 or call your local SPDR ETF
representative.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDUWSSRUWURAAA